Plasma-enhanced air treatment combining non-thermal plasma with activated carbon catalysts for high-flow-rate abatement of volatile organic compounds, odors, and airborne pathogens. Validated for virus inactivation, with demonstrated synergy in industrial odor control applications.
This technology combines non-thermal plasma with activated carbon catalysts to achieve high-efficiency air treatment at elevated gas flow rates. The approach addresses a critical challenge in air purification: maintaining high abatement performance while processing large volumes of air. By integrating plasma with activated carbon, the system leverages plasma-generated reactive oxygen species to extend carbon filter lifetime and enhance odor removal efficacy.
The technology targets three key application areas: volatile organic compound (VOC) decomposition, odor abatement in industrial exhaust streams, and inactivation of airborne pathogens including aerosolized viruses. Potential applications span industrial kitchen exhaust systems, HVAC systems in commercial and healthcare settings, and industrial ventilation where chemical or biological contaminants must be removed.
Plasma-catalyst synergy:
Validated performance:
Planned testing capabilities:
The technology has demonstrated proof-of-concept validation in two distinct application areas. Virus inactivation capability has been confirmed through wind tunnel testing under HVAC-simulated conditions, achieving at least 3 log reduction of aerosolized virus. A prior industry collaboration validated the plasma-activated carbon combination for industrial kitchen exhaust odor control, with reported significant improvements in both odor removal efficacy and carbon filter longevity.
Current development focuses on building an integrated testing system that combines the validated plasma source with activated carbon filtration to systematically evaluate chemical and odor abatement performance. Future validation work will include testing under controlled conditions relevant to specific implementation scenarios, enabling optimization of the plasma source design and assessment of energy requirements and scalability for commercial deployment.
The University of Minnesota is a flagship, comprehensive public research university spanning multiple campuses, with a large research enterprise and clinical integration. Industry engages through co-located labs on the Twin Cities campuses, access to an academic health system for clinical translation, and pilot and field-testing facilities that speed scale-up. A statewide extension network and outreach centers provide real-world sites and data partnerships across Minnesota, while proximity to a dense medtech and Fortune 500 corridor enables frequent collaboration. Research is supported by competitive federal funding, including NIH, NSF, DOE, USDA, and DoD. A dedicated technology transfer office manages IP, licensing, sponsored research agreements, and startup incubation to speed commercialization.